19-Nordehydroepiandrosterone
A steroid hormone
19-Nordehydroepiandrosterone (19-nor-DHEA) is a steroid hormone that is structurally similar to dehydroepiandrosterone (DHEA), but with the absence of a carbon atom at the 19th position. This modification results in distinct biological properties and potential applications in medicine and research.
Structure and Synthesis[edit]
19-Nordehydroepiandrosterone is a 19-nor steroid, meaning it lacks the methyl group at the 19th carbon position. This structural change is significant as it alters the hormone's interaction with androgen receptors and other biological targets. The synthesis of 19-nor-DHEA can be achieved through chemical modification of DHEA, involving the removal of the 19-methyl group.
Biological Activity[edit]
The biological activity of 19-nor-DHEA is primarily mediated through its conversion to other active metabolites. It can be converted into 19-nortestosterone (nandrolone), a potent anabolic steroid, which has implications for its use in muscle growth and bone density enhancement. The absence of the 19-methyl group reduces its androgenic activity compared to testosterone, making it a subject of interest for therapeutic applications.
Potential Applications[edit]
Due to its anabolic properties, 19-nor-DHEA has been investigated for use in conditions such as osteoporosis and muscle wasting. Its potential to enhance muscle mass and strength while minimizing androgenic side effects makes it a candidate for further research in hormone replacement therapy and sports medicine.
Safety and Regulation[edit]
As with other anabolic steroids, the use of 19-nor-DHEA is regulated in many countries due to potential health risks and its potential for abuse in sports. It is important to consider the legal status and safety profile of 19-nor-DHEA before its use in clinical or athletic settings.
Related pages[edit]
Gallery[edit]
-
Chemical structure of 19-Nordehydroepiandrosterone
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian